Predicting novel targets with Bayesian machine learning by integrating multiple biological signatures
Open accessAbstract
FMBS leverages a Bayesian framework to integrate 25 predictable biological space characterizations, capturing novel targets that traditional chemical descriptors miss, thereby enhancing target prediction accuracy through scaffold hopping.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Our prior work has successfully developed a variety of strategies to predict drug targets by integrating multiple biological signatures.
“Our prior work has successfully developed a variety of strategies to predict drug targets by integrating multiple biological signatures13”
From Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha (2025) · cites this paper as [13]
The Introduction (page not available) describes one Bayesian approach that combines 25 biological characterizations to predict drug targets and reports its validation. This supports the integration and target-prediction parts of the claim, but the paper presents a single FMBS strategy, not a variety of strategies developed in prior work. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404 · see citing works
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622 · see citing works
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224 · see citing works
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402 · see citing works
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043 · see citing works
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
Gfeller, D., Grosdidier, A., Wirth, M., Daina, A., Michielin, O. A., & Zoete, V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku293 · Cited by 1,811 · see citing works
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · see citing works
Discovery of drug mode of action and drug repositioning from transcriptional responses
Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000138107 · Cited by 816 · see citing works
Reymond, J.-L. (2015) · Accounts of Chemical Research · doi:10.1021/ar500432k · Cited by 720 · see citing works
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 598 · see citing works
Similarity-based machine learning methods for predicting drug–target interactions: a brief review
Ding, H., Takigawa, I., Mamitsuka, H., & Zhu, S. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbt056 · Cited by 427 · see citing works
A Bayesian machine learning approach for drug target identification using diverse data types
Madhukar, N. S., Khade, P. K., Huang, L., Gayvert, K. M., Galletti, G., Stogniew, M., Allen, J. E., Giannakakou, P., & Elemento, O. (2019) · Nature Communications · doi:10.1038/s41467-019-12928-6 · Cited by 267 · see citing works
Biological spectra analysis: Linking biological activity profiles to molecular structure
Fliri, A. F. J., Loging, W., Thadeio, P. F., & Volkmann, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407790101 · Cited by 190 · see citing works
Structure‐Based Approaches to Target Fishing and Ligand Profiling
Rognan, D. (2010) · Molecular Informatics · doi:10.1002/minf.200900081 · Cited by 148 · see citing works
Reverse Docking: A Powerful Tool for Drug Repositioning and Drug Rescue
Kharkar, P. S., Warrier, S. B., & Gaud, R. S. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.207 · Cited by 145 · see citing works
Recent advances and method development for drug target identification
Chan, J. N. Y., Nislow, C., & Emili, A. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.002 · Cited by 126 · see citing works
Inoue, I., Itoh, F., Aoyagi, S., Tazawa, S., Kusama, H., Akahane, M., Mastunaga, T., Hayashi, K., Awata, T., Komoda, T., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6141 · Cited by 115 · see citing works
Cheng, F., Li, W., Wu, Z., Wang, X., Zhang, C., Li, J., Liu, G., & Tang, Y. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400010x · Cited by 100 · see citing works
Bioactivity descriptors for uncharacterized chemical compounds
Bertoni, M., Duran-Frigola, M., Badia-i-Mompel, P., Pauls, E., Orozco-Ruiz, M., Guitart-Pla, O., Alcalde, V., Diaz, V. M., Berenguer-Llergo, A., Brun-Heath, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24150-4 · Cited by 92 · see citing works
Febuxostat in the management of hyperuricemia and chronic gout: a review
Tomlinson, B. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3310 · Cited by 76 · see citing works
Computational Drug Repositioning with Random Walk on a Heterogeneous Network
Luo, H., Wang, J., Li, M., Luo, J., Ni, P., Zhao, K., Wu, F., & Pan, Y. F. (2018) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2832078 · Cited by 71 · see citing works
Febuxostat Ameliorates Diabetic Renal Injury in a Streptozotocin-Induced Diabetic Rat Model
Lee, H.-J., Jeong, K. H., Kim, Y., Moon, J. Y., Lee, S. H., Ihm, C. G., Sung, J. Y., & Lee, T. W. (2014) · American Journal of Nephrology · doi:10.1159/000363421 · Cited by 67 · see citing works
Genetic-Driven Druggable Target Identification and Validation
Floris, M., Olla, S., Schlessinger, D., & Cucca, F. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.04.004 · Cited by 64 · see citing works
Becker, M. L., Visser, L. E., van Schaik, R. H. N., Albert Hofman, D., Uitterlinden, A. G., & Stricker, B. H. C. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1866 · Cited by 56 · see citing works
Rival, Y., Stennevin, A., Puech, L., Rouquette, A., Cathala, C., Lestienne, F., Dupont-Passelaigue, E., Patoiseau, J., Wurch, T., & Junquero, D. C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068254 · Cited by 53 · see citing works
Guo, F., Tang, X., Zhang, W., Wei, J., Tang, S., Wu, H., & Yang, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105077 · Cited by 53 · see citing works
Wassermann, A. M., Lounkine, E., Urbán, L., Whitebread, S., Chen, S., Hughes, K., Guo, H., Kutlina, E., Fekete, A., Klumpp, M., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb5001839 · Cited by 44 · see citing works
Williams, M. J. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.06.001 · Cited by 43 · see citing works
Laufkötter, O., Sturm, N., Bajorath, J., Chen, H., & Engkvist, O. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0376-1 · Cited by 40 · see citing works
Ji, K.-Y., Liu, C., Liu, Z., Deng, Y., Hou, T., & Cao, D. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad014 · Cited by 39 · see citing works
Self-citationAhmed, M. A. E., Morsy, E. M. E., & Ahmed, A. A. E. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.007 · Cited by 39 · see citing works
Wassermann, A. M., Lounkine, E., & Glick, M. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300607r · Cited by 38 · see citing works
The opportunities of mining historical and collective data in drug discovery
Wassermann, A. M., Lounkine, E., Davies, J. W., Glick, M., & Camargo, L. M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.004 · Cited by 34 · see citing works
Wu, G., Liu, J., & Wang, C. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0311-0 · Cited by 33 · see citing works
Lv, Q., Pan, X., Wang, D., Rong, Q., Ma, B., Xie, X., Zhang, Y., Wang, J., & Hu, L. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01184 · Cited by 32 · see citing works
Granadeiro, L., Dirks, R. P., Ortiz-Delgado, J. B., Gavaia, P. J., Sarasquete, C., Laizé, V., Cancela, M. L., & Fernández, I. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.06.042 · Cited by 23 · see citing works
A Novel Drug Repositioning Approach Based on Collaborative Metric Learning
Luo, H., Wang, J., Yan, C., Li, M., Wu, F., & Pan, Y. F. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2926453 · Cited by 20 · see citing works
Cao, D.-S., Jiang, S.-L., Guan, Y.-D., Chen, X.-S., Zhang, L.-X., Zhang, Y., Chen, A. F., Yang, J.-M., & Cheng, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112421 · Cited by 16 · see citing works
Self-citationÖzakça, I., Arıoglu, E., Güner, Ş., ALTAN, V. M., & Ozcelikay, A. T. (2007) · Pharmacology · doi:10.1159/000104876 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Jiang, S., Liu, K., Jiang, T., Li, H., Wei, X., Wan, X., Zhong, C., Gong, R., Chen, Z., Zou, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62288-7 · Cited by 23 · see citing works
“- Previous studies have demonstrated that lower concentrations of bufalin that the ones used in the present study have an inhibitory effect on the steroid receptor coactivators SRC as well as on the viability in MCF-7 breast cancer cells.”
Self-citationAdvances in bioinformatic methods for the acceleration of the drug discovery from nature
Maciejewska‐Turska, M., Georgiev, M. I., Kai, G., & Sieniawska, E. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156518 · Cited by 17 · see citing works
Application of the Rumsfeld matrix to anticancer natural product target discovery
Bailly, C. (2024) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2024.100023 · Cited by 3 · see citing works
Chen, F., Zhao, R., Han, X., Li, H., & Tang, Z. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag045 · Cited by 1 · see citing works
- Authors
- Wei, X., Zhu, T., Yip, H. F., Fu, X., Jiang, D., Deng, Y., Lu, A., & Cao, D.
- Affiliations
- Central South University (CN)
- Hong Kong Baptist University (HK)
- School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, SAR 999077, China
- Corresponding author
- Cao, Dongsheng
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2024
- Volume
- 15
- Issue
- 35
- Pages
- 14471-14484
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- PMC
- PMC11333953
- OpenAlex
- W4401706012
- Cited by
- 4
- References
- 39
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Chemical Science (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province (2020B1212030006)
- National Key Research and Development Program of China (2021YFF1201400)
- Science and Technology Program of Hunan Province (2021RC4011)
- Natural Science Foundation of Hunan Province (2022JJ80104)
- Science Fund for Distinguished Young Scholars of Hunan Province (2021JJ10068)
- National Natural Science Foundation of China (22173118, 22220102001)
- Hong Kong Baptist University (SDF19-0402-P02)
- Topics
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Keywords
- target prediction, Bayesian learning, scaffold hopping, small molecule drug targets, drug repurposing, off-target effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review